TRxADE HEALTH (MEDS) Stock Chart & Stock Price History → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free MEDS Stock Alerts $5.65 -0.40 (-6.61%) (As of 05/24/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TRxADE HEALTH Stock Price Performance5 Day Performance-1.74%1 Month Performance-9.74%3 Month Performance-31.27%6 Month Performance+0.89%Year-To-Date Performance+8.73%1 Year Performance+32.16% Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. MEDS Stock Chart for Saturday, May, 25, 2024 MEDS Chart by TradingView TRxADE HEALTH Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/24/2024$6.05$5.65-6.61%$6.07$5.6011,888 shs$7.97 million05/23/2024$5.87$6.05+3.07%$6.10$5.841,720 shs$8.53 million05/22/2024$5.88$5.87-0.17%$5.93$5.672,130 shs$8.28 million05/21/2024$5.75$5.88+2.26%$5.89$5.654,130 shs$8.29 million05/20/2024$5.84$5.75-1.54%$5.98$5.5613,016 shs$8.11 million05/17/2024$5.62$5.70+1.42%$5.84$5.4015,418 shs$8.04 million Get the Latest News and Ratings for MEDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. 05/16/2024$5.66$5.62-0.71%$6.01$5.626,029 shs$7.90 million05/15/2024$5.69$5.66-0.46%$5.83$5.664,019 shs$7.96 million05/14/2024$5.92$5.69-3.95%$5.92$5.655,016 shs$8.02 million05/13/2024$5.76$5.92+2.79%$5.94$5.534,442 shs$8.35 million05/10/2024$6.18$5.76-6.80%$6.25$5.3022,955 shs$8.10 million05/09/2024$6.09$6.18+1.48%$6.28$6.014,013 shs$8.71 million05/08/2024$5.97$6.09+2.01%$6.21$5.964,784 shs$8.59 million05/07/2024$6.06$5.97-1.49%$6.60$5.938,627 shs$8.42 million05/06/2024$6.29$6.06-3.66%$6.53$6.066,457 shs$8.55 million05/03/2024$6.01$6.17+2.66%$6.32$6.0211,693 shs$8.70 million05/02/2024$6.05$6.01-0.66%$6.44$5.8910,103 shs$8.47 million05/01/2024$5.96$6.05+1.51%$6.18$5.822,449 shs$8.53 million04/30/2024$6.30$5.96-5.40%$6.50$5.967,471 shs$8.40 million04/29/2024$6.31$6.30-0.16%$6.88$5.9212,271 shs$8.88 million04/26/2024$6.26$6.02-3.83%$6.42$5.8214,603 shs$8.49 million04/25/2024$6.42$6.26-2.49%$6.70$5.9520,336 shs$8.80 million04/24/2024$6.50$6.42-1.23%$6.83$6.2916,467 shs$7.77 million04/23/2024$6.66$6.50-2.40%$6.80$6.259,411 shs$7.87 million04/22/2024$6.43$6.66+3.58%$7.08$6.4328,113 shs$8.06 million04/19/2024$6.93$6.43-7.22%$7.25$6.3573,499 shs$7.78 million04/18/2024$7.08$6.93-2.12%$7.40$6.2974,296 shs$8.39 million04/17/2024$7.06$7.08+0.28%$7.68$6.7851,728 shs$8.57 million04/16/2024$7.30$7.06-3.29%$7.62$7.0621,276 shs$8.51 million04/15/2024$7.31$7.30-0.14%$7.68$7.015,917 shs$8.83 million04/12/2024$7.90$7.31-7.47%$8.50$7.2459,801 shs$8.85 million04/11/2024$8.30$7.90-4.82%$8.58$7.6621,648 shs$9.52 million04/10/2024$8.91$8.30-6.85%$9.05$8.1919,179 shs$10.04 million04/09/2024$9.06$8.91-1.66%$9.18$8.915,876 shs$10.78 million04/08/2024$9.34$9.06-3.00%$9.43$9.0614,897 shs$10.96 million04/05/2024$10.12$9.34-7.71%$10.19$8.5968,376 shs$11.30 million04/04/2024$10.37$10.12-2.41%$10.35$9.8824,866 shs$12.25 million04/03/2024$9.99$10.37+3.80%$10.55$9.7312,710 shs$12.55 million04/02/2024$9.64$9.99+3.63%$9.99$9.4112,818 shs$12.09 million04/01/2024$10.24$9.64-5.86%$9.99$9.2517,553 shs$11.66 million348 million Americans lives to END as we know it? (Ad)348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today...To see my free research, simply click here now.03/29/2024$10.24$10.24$10.74$8.53113,383 shs$12.39 million03/28/2024$9.55$10.24+7.23%$10.74$9.01113,126 shs$12.39 million03/27/2024$9.28$9.55+2.91%$10.00$9.3564,806 shs$11.56 million03/26/2024$9.51$9.28-2.42%$10.75$9.05136,431 shs$11.18 million03/25/2024$24.07$9.51-60.49%$15.91$9.25262,136 shs$11.51 million03/22/2024$21.65$24.07+11.18%$25.80$20.99107,539 shs$29.13 million03/21/2024$20.04$21.65+8.03%$22.00$19.6134,165 shs$26.20 million03/20/2024$20.68$20.04-3.09%$21.31$18.0530,314 shs$24.25 million03/19/2024$19.50$20.68+6.05%$20.86$14.62130,659 shs$25.02 million03/18/2024$28.80$19.50-32.29%$27.56$18.33164,780 shs$23.60 million03/15/2024$29.15$28.80-1.20%$30.05$25.03102,202 shs$34.85 million03/14/2024$25.94$29.15+12.37%$30.00$24.64148,812 shs$35.27 million03/13/2024$33.90$25.94-23.48%$33.28$24.00247,708 shs$31.39 million03/12/2024$32.72$33.90+3.61%$34.80$30.09190,540 shs$40.85 million03/11/2024$25.53$32.72+28.16%$44.56$28.00773,290 shs$39.59 million03/08/2024$19.00$25.53+34.37%$25.53$18.66449,803 shs$30.89 million03/07/2024$17.26$19.00+10.08%$19.00$16.55540,832 shs$22.99 million03/06/2024$8.33$17.26+107.21%$21.22$10.759.23 million shs$20.89 million03/05/2024$9.00$8.33-7.45%$9.01$7.7941,649 shs$10.08 million03/04/2024$9.18$9.00-1.96%$9.55$8.4143,836 shs$10.89 million03/01/2024$9.52$9.18-3.57%$9.69$9.0311,701 shs$11.11 million02/29/2024$8.50$9.52+12.00%$9.56$8.4042,933 shs$11.52 million02/28/2024$8.40$8.50+1.19%$8.64$8.1067,337 shs$10.29 million02/27/2024$8.58$8.40-2.10%$8.83$8.32125,844 shs$10.12 million02/26/2024$8.22$8.58+4.38%$8.84$8.00108,799 shs$10.38 million Related Companies: Cosmos Health Stock Chart BIMI Stock Chart TransCode Therapeutics Stock Chart Graybug Vision Stock Chart IM Cannabis Stock Chart BioRestorative Therapies Stock Chart Vaccinex Stock Chart NeuroMetrix Stock Chart ASLAN Pharmaceuticals Stock Chart GT Biopharma Stock Chart Receive MEDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MEDS) was last updated on 5/25/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin AnalyticsVIPs Only (Do NOT Share This)Profits Run[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyA personal note from Behind The Markets' CEO Dylan Jovine...Behind the MarketsDo NOT Buy: Nvidia, Apple, Microsoft, Tesla, Meta, or Any ‘Big Tech’ Stock…InvestorPlaceThis military-backed stock “owns” AI marketPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.